Le Dr Girinath M. R. est un chirurgien cardiaque pionnier, reconnu pour son expertise en matière de chirurgies cardiaques complexes et de soins exceptionnels aux patients.
Regain your heart health with Dr. K R Balakrishnan, leading heart transplant surgeon at Fortis Chennai. Known for his surgical excellence and compassionate care, he's helped countless patients with end-stage heart failure live healthier lives.
PF Night Splint Compared to plantar based splints, patients prefer dorsal models because they are less bulky, cooler, lower profile and easier to walk in at night. PF Night Splint includes all of these features and more. Neoprene calf and toe straps along with gel padding on the top of the foot help reduce pressure points and the plastic-free bottom offers safer nighttime ambulation. Even added more room in the forefoot to accommodate wider feet and new flexible shell allows easier nighttime ambulation without compromising the ability to hold the foot at 90° during rest. Finally, a plantar fasciitis splint patients will wear all night! Neoprene calf. Padded foam liner. Fits right or left. Not made with natural rubber latex.
PF Night Splint (Derotation)
Applications
Prevention and correction of foot drop.
Night splint for early healing.
Ambulatory, can be used as a day splint.
Perfect post-operative immobilisation and derotation.
Peroneal / Peritibial nerve or muscle damage.
Ankle or Plantar flexion contracture and functional alignment.
Can be used to protect the diabetic/ injured ankle & foot.
PF Night Splint (Derotation) Features
Removable de-rotation bar.
Moulded foot casing, aesthetically pleasing and durable.
Effective Liner, improved comfort.
Highly functional Design, customized degree of dorsiflexion.
Double strapping mechanism, better grip.
Tynor R O M Knee Brace
Prefabricated, custom adjusted R.O.M. Knee Brace controls and restrict flexion/extension of the knee joint through a multi-point joint fixation system to allow a range of motion or immobilization to the knee. Universal design allows it to be used on quite a big range of population and for a multiple orthopedic problems associated with knee joint.
Immobilization at any angle
Controlled motion between any two angles
Quick and easy application and removal.
Tynor R O M Knee Brace Features
R.O.M. Dial
0 to 120 degree flexion.
0 to 60 degree hyper extention
Locking at any
Global drug discovery services market will continue to grow, owing to upsurge in externalization of R&D activities, rising expenditure on R&D, and increasing incidence of chronic diseases. Expiration of patents boosting the demand for drug discovery and the introduction of innovative drug discovery technologies are projected to support the market growth during the forecast period 2019-2025.
The global drug discovery services market, by type, is segmented into medicinal chemistry services, biology services, and pharmacokinetics and drug metabolism. Among these, the medicinal chemistry services segment accounted for the largest share in 2018 and is expected to grow at a high-double-digit CAGR by 2025. Increasing tendency of pharma companies to externalize discovery & development services, upsurge in the number of drug discovery & development activities, and growing R&D expenditure are the key factors driving the growth of the segment.
Dr. K R Balakrishnan, best cardiac surgeon for heart failure in India, offers heart transplant surgeries with outcomes that rank among the finest in the nation.
PF Night Splint (Derotation)
Applications
Prevention and correction of foot drop.
Night splint for early healing.
Ambulatory, can be used as a day splint.
Perfect post-operative immobilisation and derotation.
Peroneal / Peritibial nerve or muscle damage.
Ankle or Plantar flexion contracture and functional alignment.
Can be used to protect the diabetic/ injured ankle & foot.
PF Night Splint (Derotation) Features
Removable de-rotation bar.
Moulded foot casing, aesthetically pleasing and durable.
Effective Liner, improved comfort.
Highly functional Design, customized degree of dorsiflexion.
Double strapping mechanism, better grip.
Dr. K R Balakrishnan is a leading cardiac surgeon in India, specializing in heart transplant surgery. With extensive experience and numerous successful transplants, he is dedicated to providing top-tier cardiac care. Currently serving as the Director of Cardiac Sciences at MGM Healthcare in Chennai, Dr. Balakrishnan continues to make a profound impact on heart transplant services in India.
Looking for the best care for heart failure in India? Dr. K R Balakrishnan is a renowned cardiologist known for his advanced treatments and compassionate approach. Trust your heart and get the best!
Meet Dr K R Balakrishnan - one of India's top cardiologists, known for his groundbreaking work in heart transplantation and advanced cardiac care. The name you can trust in life-saving cardiac treatment. ❤️
Rencontrez le Dr K. R. Balakrishnan, l'un des meilleurs cardiologues indiens, reconnu pour ses travaux révolutionnaires en transplantation cardiaque et ses soins cardiaques de pointe. Une référence en matière de traitements cardiaques vitaux.
Ergonomic wheelchair series provides users with a large selection of ultra lightweight wheelchairs that can help improve life. This series has features that include a high strength lightweight frame, foldable and easy to store, breathable anti-bacterial, anti-staining, removable and machine washable cushion. Also includes the exclusive S-Shape Seating System, which provides increased stability, better weight distribution and lowers the risk of pressure sores and spinal injury. The patented S-Shape Seating System that comes with every wheelchair model in this series provides an ergonomic seating frame that conforms and flexes to the shape of body.
Karma S Ergo 106 Wheelchair:
The Karma S Ergo Lightweight 106 Wheelchair has a special S-style ergonomic frame and a three position angle adjustable back. It features fixed footrests and a "tube-in center" footplate that assures better side leg support. The backrest easily folds for transportation and storage and it also features a pouch for carrying small items. A 1/4" thick silver colored anti-bacterial cushion is standard, it is odor and stain resistant and is machine washable. Comes standard with an 18" seat width.
Karma S Ergo 106 Wheelchair Features:
High Strength, weighs only 12 kg. (w/ footrests)
Fixed Armrest & Footrest w/anti-tippers
Tube-in Center" footplate, assures better side leg support
Seat Width: 18"x17"
S-Style Ergonomic Seat
Fixed armrests w/ Wider Concaved Armpads
Anti-Tippers standard on this model
3 easy backrest angle adjustments: "Working" Angle (95°), (100°) & Angle (105°)
Aegis Anti-Bacterial Upholstery
Rigidifying push-bar, allows stability for user and companion - collapsible with chair
24' Rear polyurethane, high tread, flat free wheels
Folding Backrest/ Folding seat for easy travel
Extending push to lock manual breaks
Pouch for carrying small items attached to upholstery behind backrest
Upholstery: Silver ¼" Anti-Bacterial cushion AEGIS, removable, mach
Rise in R&D of coronary stents and untapped emerging countries are expected to provide new market opportunities to coronary stents manufacturers in the near future.
To get relief from and treatment the of respiratory disease at hospitals, clinics, home, traveling and emergency situations various medical devices have been developed. The respiratory devices are used to provide medication to the lungs and supply the proper amount of ambient air or oxygen to a patient. Most of the devices are used as a non-invasive form of therapy for patients. Respiratory drugs and devices companies are concentrating on developing new products. Companies are expanding their product portfolios and increasing their R&D budget. Major respiratory devices include therapeutic devices such as masks, ventilators, humidifiers, positive airway pressure devices and other devices. Other respiratory devices include diagnostic and monitoring devices and consumables and accessories meters.
Immunodiagnostics occupied the highest share of the market in 2016 and is expected to maintain the lead during the forecast period owing to the introduction of novel reagents and an increase in R&D. UK IVD market accounted for $ 2,148 million in 2016 and is estimated to reach $3,127 million by 2023, growing at a CAGR of 5.4%
the "Global Lung Cancer Drugs Market" will grow at a CAGR of 13.6% during the forecast period. The market has witnessed steady growth in the past few years with the introduction of novel products, which have augmented the acceptance of immunotherapy drugs in the market. The market is fueled by upsurge in the incidence of lung cancer cases across the globe - owing to increasing diagnosis rate and mainly due to increasing tobacco consumption, increase in the lung cancer treatment rates, increasing rate of effective drug approvals as first-line therapies, strategic deals to develop new products, increasing R&D spending, and rapid industrialization leading to increased pollution.
The report provides complete details about the sub-segments of the lung cancer drugs market. Through this report, the key stakeholders can know about the major trends, drivers, investments, vertical player's initiatives, and government initiatives towards the disease management in the upcoming years along with details of the existing pureplay companies and new players entering the market.
The global intravascular ultrasound (IVUS) market size is expected to reach USD 3.53 billion by 2025 at a 7.6% CAGR during the forecast period. Rising investments in the medtech industry, increasing R&D activities, and surge in product launches are key factors driving the market.